Literature DB >> 26779777

The importance of source control in the management of severe skin and soft tissue infections.

Christian Eckmann1.   

Abstract

PURPOSE OF REVIEW: Recent studies mainly deal with the relevance of antibiotics in the treatment of complicated skin and soft tissue infections (cSSTIs) with or without sepsis. The impact of surgical source control for severely ill patients with sepsis is underrepresented in the literature. This review tries to add new information on this topic. RECENT
FINDINGS: Source control in cSSTI ranges from removal of central venous catheters to radical debridement of extensive body areas. Necrotizing soft tissue infections serve as a model disease for the value of surgical measures in severe cSSTI. Early diagnosis and timing of surgical intervention, the necessary extent of surgery and the assessment of adjunctive therapies (hyperbaric oxygenation, intravenous immunoglobulins) have been recently investigated.
SUMMARY: The evidence for simple source control measures (i.e., opening and drainage of an abscess) remains low, but appears to be self-evident. Radical debridement remains the standard of care for those patients with soft tissue sepsis because of necrotizing soft tissue infections. Surgical treatment should be performed latest within 12 h after admission. The value of other adjunctive measures (hyperbaric oxygen therapy, intravenous immunoglobulins) is uncertain. Only an aggressive approach offers the possibility to save life and limbs of the affected patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26779777     DOI: 10.1097/QCO.0000000000000240

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  6 in total

1.  Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.

Authors:  Martin B Madsen; Peter B Hjortrup; Marco B Hansen; Theis Lange; Anna Norrby-Teglund; Ole Hyldegaard; Anders Perner
Journal:  Intensive Care Med       Date:  2017-04-18       Impact factor: 17.440

2.  In 2035, will all bacteria be multidrug resistant? We are not sure.

Authors:  Kevin B Laupland; Etienne Ruppé; Stephan Harbarth
Journal:  Intensive Care Med       Date:  2016-04-18       Impact factor: 17.440

Review 3.  Current understanding in source control management in septic shock patients: a review.

Authors:  Leonel Lagunes; Belen Encina; Sergio Ramirez-Estrada
Journal:  Ann Transl Med       Date:  2016-09

4.  Clinical, diagnostic, and therapeutic features of patients admitted to acute care hospitals with trunk compared to lower limb cellulitis.

Authors:  Anat Zalmanovich; Michael Lishner; Sharon Reisfeld
Journal:  Intern Emerg Med       Date:  2017-06-07       Impact factor: 3.397

5.  Essentials in the management of necrotizing soft-tissue infections.

Authors:  Norma Jung; Christian Eckmann
Journal:  Infection       Date:  2019-05-10       Impact factor: 3.553

6.  High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant Acinetobacter baumannii: An Observational Cohort Study.

Authors:  Hui Han; Weidong Qin; Yue Zheng; Dongming Cao; Haining Lu; Lu Zhang; Yi Cui; Yuanyuan Hu; Wei Li; Haipeng Guo; Dawei Wu; Chen Li; Hao Wang; Yuguo Chen
Journal:  Infect Drug Resist       Date:  2021-09-18       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.